Business Context and Reporting Period
Company: CorMedix Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 8, 2020
Reporting Period: Event-based report regarding corporate governance changes.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a current report focused on corporate bylaws amendments.
Material Changes
On October 8, 2020, the Board of Directors approved an amendment to the Company's Amended and Restated Bylaws (now the Second Amended and Restated Bylaws). The primary change permits the annual meeting of stockholders to be conducted via remote communication, effective immediately.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The sole purpose is to disclose the amendment to the Bylaws.
Key Facts for Investor Verification
- The Company's Bylaws have been amended to allow for remote stockholder meetings.
- The amendment was approved by the Board of Directors on October 8, 2020.
- The Second Amended and Restated Bylaws are filed as Exhibit 3.1.
- No financial performance data is included in this specific filing.